When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Section 4.2 - Details regarding average period of treatment and continued periods of treatment added. Section 4.4 - Cross-reference to Section 5.3 regarding carcinogenic effects added. Added warnings regarding excipients of known effect. Section 4.5 - Details regarding disulfiram-like reactions added.
Section 4.7 – Standard wording updated Section 4.8 - Changed formatting Section 4.9 - Added extra details regarding overdose Section 10 - Date updated
Change to Section 7 - Change in office address of Marketing Authorisation holder